Showing results (481-490 of 1,988) with videos related to

Sort By:
Pageof 199
Prostate Cancer and Prostatic Diseases|April 5, 2026
Practical management of hematuria after endoscopic surgery for benign prostatic obstructionAlexis E Te, Austen G Te, Ashwin Ramaswamy, et al.
Prostate Cancer and Prostatic Diseases|November 9, 2019
Feasibility and continence outcomes of extended prostatic urethral preservation during robot-assisted radical prostatectomyLuciano A Nunez Bragayrac, Ahmed A Hussein, Kristopher Attwood, et al.
Prostate Cancer and Prostatic Diseases|December 14, 2018
Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift StudyDaniel Rukstalis, Douglas Grier, Sean P Stroup, et al.
Prostate Cancer and Prostatic Diseases|June 20, 2026
Efficacy and safety of darolutamide plus androgen-deprivation therapy in Black patients with metastatic hormone-sensitive prostate cancer from the phase 3 ARANOTE trialQuoc-Dien Trinh, Daniel J George, Neal Shore, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Adenovirus-mediated gene transfer in dog prostate: a preclinical study of a relevant model system for gene therapy of human prostatic cancerM Andrawiss, P Opolon, K Benihoud, et al.
Prostate Cancer and Prostatic Diseases|June 25, 2026
A nationwide histopathology study reflecting the impact of the introduction of MRI in the diagnostic trajectory of prostate cancer in routine clinical careAnne M A Prinsen, Stefan Slagter, Ivo G Schoots, et al.
Prostate Cancer and Prostatic Diseases|May 28, 2026
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progressionFabio Turco, Silke Gillessen, Giuseppe Salfi, et al.
Prostate Cancer and Prostatic Diseases|May 22, 2026
Antifibrotic therapy for Lower Urinary Tract Symptoms secondary to Benign Prostatic HyperplasiaAjinkya R Limkar, Kevin T McVary, William A Ricke, et al.
Prostate Cancer and Prostatic Diseases|June 12, 2026
Association between concomitant ACEI/ARBs use and survival of patients with prostate cancer receiving abiraterone acetate: A post-hoc analysis of two randomized trialsJunliang Zhao, Xinyang Cai, Zijun Mo, et al.
Prostate Cancer and Prostatic Diseases|August 5, 2026
Germline genetic risk and prostate cancer-specific mortality in a population-based incident cohortLucy Lu, Julian Xu, Zhuqing Shi, et al.
Pageof 199